Literature DB >> 3588680

Force-time measurements of knee muscle functions of subjects with multiple sclerosis.

W Y Chen, F M Pierson, C N Burnett.   

Abstract

The purpose of this study was to determine whether the time-rate of muscle tension development, the muscle tension-maintaining capacity, and the reciprocal inhibition time of muscles in subjects with multiple sclerosis were significantly different from those of healthy subjects. An isokinetic dynamometer was used to evaluate the quadriceps femoris and hamstring muscles of 15 Experimental Group subjects with multiple sclerosis and 17 healthy Control Group subjects. The muscles were tested isometrically at 45 degrees of knee flexion and isokinetically at speeds of 30 degrees/sec and 90 degrees/sec. The subjects with multiple sclerosis demonstrated a significant (p less than .001) slowing of the time-rate of muscle tension development and a significant (p less than .005) decrease in muscle tension-maintaining capacity when compared with healthy subjects. The difference in the reciprocal inhibition time of muscles of the Experimental and Control Groups was not significant. When the reciprocal inhibition time of muscles was expressed as a percentage of the total torque curve, however, a significant prolongation (p less than .001) was observed in the subjects with multiple sclerosis.

Entities:  

Mesh:

Year:  1987        PMID: 3588680     DOI: 10.1093/ptj/67.6.934

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  3 in total

1.  A reduced somatosensory gating response in individuals with multiple sclerosis is related to walking impairment.

Authors:  David J Arpin; James E Gehringer; Tony W Wilson; Max J Kurz
Journal:  J Neurophysiol       Date:  2017-07-19       Impact factor: 2.714

Review 2.  Exercise and multiple sclerosis.

Authors:  Lesley J White; Rudolph H Dressendorfer
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

3.  Exercise in multiple sclerosis -- an integral component of disease management.

Authors:  Andrea Döring; Caspar F Pfueller; Friedemann Paul; Jan Dörr
Journal:  EPMA J       Date:  2011-12-24       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.